Trends-in-Medicine has no financial connections with any pharmaceutical or medical device company. The information and opinions expressed have been compiled or arrived at from sources believed to be reliable and in good faith, but no liability is assumed for information contained in this newsletter. Copyright ©2013. No articles may be reproduced without written permission of the publisher.

Archives

American College of Cardiology: Drugs

American Society for Clinical Pharmacology and Therapeutics

What is the Outlook for AstraZeneca's Iressa?

American College of Cardiology -- Devices

Questions about the Safety of Bisphosphonates

Cox-2 Inhibitors and NSAIDs Safe Enough to Remain on the Market

Tysabri Suddenly Pulled from Market

International Conference on Anti-Cancer Therapy (Icact )

Cosmetic Surgery Update

American Heart Association

Shire Pharmaceuticals' Adderall XR for ADHD: Off the Market in Canada

Inspire Pharmaceuticals' Diquafosol For Dry Eye: Fails Phase III Trial

Cardiac Surgery Update

Cosmetic Surgery Update

Results of Novartis’s Femara BIG-1-98 Trial

Search

Events Calendar

Categories

Get Adobe Reader

Disclaimer